Home›Companies›Healthcare›StromaGenesis

StromaGenesis LLC

Develops cancer tests to help clinicians assess prognosis and potential treatment response.

Updated Nov 10, 2026·Latest SEC filing May 28, 2026·Suggest an edit

About StromaGenesis

StromaGenesis is a private company based in Wynnewood, Pennsylvania, incorporated in 2022 in Delaware. It has reported $175,000 raised in one offering on Form D since May 2026. Its chief executive is Richard Pestell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 25, 2026May 28, 2026$175,000of $10.0M target1$175KSAFEsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on StromaGenesis's Form D filed May 28, 2026.

Sources

  1. SECStromaGenesis LLC filing history